Bernard H. Bochner

1992–2025 年に発表

別表記
Bernard H Bochner
115
論文数
35,844
被引用数
81
h 指数
111
i10 指数

被引用数

Bernard H. Bochner の年別被引用数1945 年: 被引用 1 件1952 年: 被引用 1 件1976 年: 被引用 1 件1977 年: 被引用 1 件1992 年: 被引用 3 件1995 年: 被引用 1 件1996 年: 被引用 3 件1997 年: 被引用 7 件1998 年: 被引用 10 件1999 年: 被引用 8 件2000 年: 被引用 23 件2001 年: 被引用 21 件2002 年: 被引用 29 件2003 年: 被引用 58 件2004 年: 被引用 71 件2005 年: 被引用 57 件2006 年: 被引用 89 件2007 年: 被引用 106 件2008 年: 被引用 66 件2009 年: 被引用 108 件2010 年: 被引用 120 件2011 年: 被引用 146 件2012 年: 被引用 136 件2013 年: 被引用 140 件2014 年: 被引用 203 件2015 年: 被引用 201 件2016 年: 被引用 250 件2017 年: 被引用 280 件2018 年: 被引用 362 件2019 年: 被引用 1,297 件2020 年: 被引用 1,685 件2021 年: 被引用 1,381 件2022 年: 被引用 1,086 件2023 年: 被引用 857 件2024 年: 被引用 1,274 件2025 年: 被引用 562 件2026 年: 被引用 23 件1946〜1951 年は被引用が無いため表示していません1953〜1975 年は被引用が無いため表示していません1978〜1991 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,060 件、この内訳の 27.1%中国: 引用元論文 1,823 件、この内訳の 12.2%イタリア: 引用元論文 849 件、この内訳の 5.7%ドイツ: 引用元論文 811 件、この内訳の 5.4%イギリス: 引用元論文 797 件、この内訳の 5.3%カナダ: 引用元論文 646 件、この内訳の 4.3%フランス: 引用元論文 559 件、この内訳の 3.7%日本: 引用元論文 505 件、この内訳の 3.4%スペイン: 引用元論文 490 件、この内訳の 3.3%オランダ: 引用元論文 438 件、この内訳の 2.9%スイス: 引用元論文 351 件、この内訳の 2.3%オーストリア: 引用元論文 314 件、この内訳の 2.1%
0%27.1%その他 22.3%

分野

  • Medicine70.7%
  • Biochemistry, Genetics and Molecular Biology23.5%
  • Immunology and Microbiology2.9%
  • Computer Science1.1%
  • Engineering0.4%
  • Neuroscience0.2%
  • その他1.2%

トピック

  • Bladder and Urothelial Cancer Treatments12.2%
  • Urinary and Genital Oncology Studies6.6%
  • Cancer Immunotherapy and Biomarkers6.6%
  • Cancer Genomics and Diagnostics5.3%
  • Ferroptosis and cancer prognosis3.3%
  • Epigenetics and DNA Methylation2.4%
  • その他63.6%

共著者

全論文

検索で開く
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  2. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  3. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  4. Comprehensive molecular characterization of urothelial bladder carcinoma Open

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David J. Kwiatkowski, Andrew D. Cherniack, Weiguo Jian, Chandra Sekhar Pedamallu, Richard C. Gibbs, Seth P. Lerner, Kristian Cibulskis, Patricia Garrido Castro, Andrey Sivachenko, Chip Stewart, Michael S. Lawrence, Whitney D. McClenden, Margaret Morgan, Richard C. Gibbs, Scott L. Carter, Chad J. Creighton, Lawrence A. Donehower, Chad J. Creighton, C. Smith, Ami S. Bhatt, Trevor Pugh, Gordon Saksena, Lee Lichtenstein, Michael S. Lawrence, Carrie Sougnez, Kristian Cibulskis, Daniel DiCara, Petar Stojanov, Steven E. Schumacher, Doug Voet, Yingchun Liu, Jaegil Kim, Petar Stojanov, Doug Voet, Pei Lin, Hailei Zhang, Scott L. Carter, Scott Frazer, Michael S. Noble, Daniel DiCara, Lihua Zou, Bernard H. Bochner, Nils Gehlenborg, Ilana R. Garcia-Grossman, David I. Heiman, Juok Cho, Rameen Beroukhim, Dmitry A. Gordenin, David J. Kwiatkowski, Ami S. Bhatt, Andrey Sivachenko, Joonil Jung, Chip Stewart, Andrew D. Cherniack, Samuel S. Freeman, Eric Lander, Michael S. Noble, Tod D. Casasent, David J. Van Den Berg, David J. Kwiatkowski, Nikolaus Schultz, David J. Kwiatkowski, Jianjiong Gao, Anders Jacobsen, B. Arman Aksoy, Ami S. Bhatt, Petar Stojanov, Chandra Sekhar Pedamallu, Rameen Beroukhim, William Lee ほか 194 名 - Nature, Nat. 2014 被引用: 3,086

  5. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)

    著者: , , , , , , , , , , , , , , , , , - European Urology 2018 被引用: 636

  6. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

    著者: , , , , , , , , , , , , , - The Journal of Urology 2017 被引用: 940

  7. The mechanism of action of BCG therapy for bladder cancer—a current perspective

    著者: , , - Nature Reviews Urology 2014 被引用: 709

  8. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2001 被引用: 3,539

  9. Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stacey Gabriel, Alan D. D’Andrea, Levi A. Garraway, Jonathan E. Rosenberg - Cancer Discovery 2014 被引用: 624

  10. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 被引用: 69

  11. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

    著者: , , , , , , , , , , , , , , , , , - European Urology 2017 被引用: 372

  12. Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

    著者: , , , , , , , , , , - European Urology 2008 被引用: 1,399

  13. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan E. Rosenberg, Min Yuen Teo, Dean F. Bajorin - Journal of Clinical Oncology 2023 被引用: 105

  14. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun Vasant Balar, Amir Mortazavi, Jonathan E. Rosenberg - Journal of Clinical Oncology 2022 被引用: 99

  15. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer

    著者: , , , , , , , - Cancer 2008 被引用: 357

  16. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 被引用: 70

  17. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort

    著者: , , , , , , , , , , , - European Urology 2021 被引用: 102

  18. Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder

    著者: , , , , , , - Cancer 2006 被引用: 433

  19. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 283

  20. Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 被引用: 67

  21. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

    著者: , , , , , , , , , , , , , , - European Urology 2014 被引用: 597

  22. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis

    著者: , , , , , , , , , , , - European Urology Oncology 2020 被引用: 171

  23. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 279

  24. Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 被引用: 131